Intelligent Bio Solutions...

NASDAQ: INBS · Real-Time Price · USD
1.47
-0.01 (-0.68%)
At close: Aug 15, 2025, 2:14 PM

Intelligent Bio Solutions Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-10.19M -10.66M -8.33M -7.06M
Depreciation & Amortization
1.21M 966.73K n/a n/a
Stock-Based Compensation
230.5K 260K n/a n/a
Other Working Capital
-135.51K 554.75K 2.2M -3.97M
Other Non-Cash Items
-122.29K -1.76M 2.54M 704.36K
Deferred Income Tax
n/a 3.74M n/a n/a
Change in Working Capital
-701.93K 78.92K 2.44M -4.94M
Operating Cash Flow
-9.57M -7.38M -3.36M -11.3M
Capital Expenditures
-221.43K -505.12K -380.22K n/a
Cash Acquisitions
n/a -189.02K n/a n/a
Purchase of Investments
n/a n/a -500K n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -868.62K -500K n/a
Investing Cash Flow
-221.43K -694.14K -880.22K n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -1.34M n/a -1.49M
Financial Cash Flow
14.56M 1.44M n/a 23.4M
Net Cash Flow
4.77M -6.7M -4.34M 12.15M
Free Cash Flow
-9.79M -7.88M -3.74M -11.3M